CVRx, Inc. (CVRX)

NASDAQ: CVRX · Real-Time Price · USD
15.52
0.00 (0.00%)
Nov 8, 2024, 4:00 PM EST - Market closed
0.00%
Market Cap 376.57M
Revenue (ttm) 47.26M
Net Income (ttm) -58.48M
Shares Out 24.26M
EPS (ttm) -2.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 283,173
Open 15.66
Previous Close 15.52
Day's Range 15.49 - 15.95
52-Week Range 6.40 - 33.14
Beta 1.11
Analysts Buy
Price Target 15.83 (+2.0%)
Earnings Date Oct 29, 2024

About CVRX

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 an... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jun 30, 2021
Employees 200
Stock Exchange NASDAQ
Ticker Symbol CVRX
Full Company Profile

Financial Performance

In 2023, CVRx, Inc.'s revenue was $39.30 million, an increase of 74.89% compared to the previous year's $22.47 million. Losses were -$41.20 million, -0.55% less than in 2022.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for CVRX stock is "Buy." The 12-month stock price forecast is $15.83, which is an increase of 2.00% from the latest price.

Price Target
$15.83
(2.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

CVRx: Impressive Top-Line Growth Seems Priced In

CVRx's Barostim therapy shows strong clinical success and impressive revenue growth. Recent reimbursement approvals from CMS enhance Barostim's sales potential. Despite double-digit sales growth and a...

3 days ago - Seeking Alpha

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

CVRx, Inc. (NASDAQ:CVRX) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Mike Vallie - Investor Relations Kevin Hykes - President & Chief Executive Officer Jared Oas...

11 days ago - Seeking Alpha

CVRx announces new CPT® Category I codes for Barostim

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® Editorial...

22 days ago - GlobeNewsWire

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an inno...

25 days ago - GlobeNewsWire

CVRx Announces Appointment of Two New Board Members

Kevin Ballinger and Mitch Hill appointed as new independent Board members Kevin Ballinger and Mitch Hill appointed as new independent Board members

2 months ago - GlobeNewsWire

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx” or “the Company”) (...

2 months ago - GlobeNewsWire

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

2 months ago - Accesswire

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

2 months ago - Accesswire

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("C...

3 months ago - Accesswire

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

3 months ago - Accesswire

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

3 months ago - Accesswire

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

3 months ago - Accesswire

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CV...

3 months ago - Accesswire

CVRx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CVRX

LOS ANGELES , Aug. 5, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against CVRx, Inc. ("CVRx" or "the Company") (NASDAQ: CVRX) for violations of §§10(b) and 20(a)...

3 months ago - PRNewsWire

CVRX Investors Have Opportunity to Join CVRx, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , Aug. 5, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or...

3 months ago - PRNewsWire

CVRx Announces Increased Inpatient Payment for Barostim Procedure

MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS) has ...

3 months ago - GlobeNewsWire

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord Gen...

3 months ago - GlobeNewsWire

CVRx, Inc. (CVRX) Q2 2024 Earnings Call Transcript

CVRx, Inc. (NASDAQ:CVRX) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Mike Vallie - IR Kevin Hykes - President and CEO Jared Oasheim - CFO Conference Call Participan...

3 months ago - Seeking Alpha

CVRx Reports Second Quarter 2024 Financial and Operating Results

MINNEAPOLIS, July 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromo...

3 months ago - GlobeNewsWire

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an inno...

4 months ago - GlobeNewsWire